Patent · US Active

Substituted pyridazinones for the treatment of tumors

US9212146B2 · kind B2 · utility

4Cited by

3References

12Claims

0Family size

Assignee

SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES · CN

Inventors

Youhong Hu · Shanghai, CN
Liguang Lou · Shanghai, CN
Shijun Lin · Shanghai, CN
Hongbing Zhao · Shanghai, CN
Zhende Liu · Hangzhou City, CN
Yongping Xu · Shanghai, CN
Bo Chao · Summit, US

Key dates

Filing date	Jun 18, 2013
Grant date	Dec 15, 2015
Priority date	—
Expiry date	Aug 16, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a class of pyridazinones of formula I, which comprises 6-[3-(trifluoromethyl)phenyl]pyridazin-3(2H)-one as a mother nucleus, the preparation method thereof and the use thereof in manufacturing medicaments against tumors, especially liver cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.